Variant report
Variant | rs2500423 |
---|---|
Chromosome Location | chr20:25374882-25374883 |
allele | C/T |
Outlinks | Ensembl   UCSC |
- TF binding region (count:2)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:2 , 50 per page) page:
1
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ABHD12 | TF binding region |
ENSG00000100997 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs1047171 | 0.85[ASN][1000 genomes] |
rs11087520 | 0.81[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs11087521 | 0.84[AFR][1000 genomes];0.83[AMR][1000 genomes];0.81[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs11699203 | 0.81[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs12428 | 0.85[ASN][1000 genomes] |
rs13038834 | 0.82[AMR][1000 genomes];0.81[EUR][1000 genomes];0.81[ASN][1000 genomes] |
rs1888995 | 0.93[ASN][1000 genomes] |
rs2027003 | 0.85[AFR][1000 genomes];0.92[AMR][1000 genomes] |
rs2027004 | 0.88[AFR][1000 genomes];0.92[AMR][1000 genomes] |
rs2151144 | 0.80[AMR][1000 genomes];0.90[ASN][1000 genomes] |
rs2179459 | 0.82[AMR][1000 genomes] |
rs2184000 | 0.81[AMR][1000 genomes];0.81[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs2263204 | 0.88[AMR][1000 genomes];0.85[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs2387880 | 0.81[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs2387881 | 0.82[AMR][1000 genomes];0.84[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs2387882 | 0.81[AMR][1000 genomes];0.81[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs2387883 | 0.81[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs2387884 | 0.81[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs2387885 | 0.88[AFR][1000 genomes];0.89[AMR][1000 genomes];0.81[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs2387887 | 0.85[ASN][1000 genomes] |
rs2424712 | 0.90[ASN][1000 genomes] |
rs2424713 | 0.91[AFR][1000 genomes];0.89[AMR][1000 genomes];0.93[ASN][1000 genomes] |
rs2424714 | 0.90[ASN][1000 genomes] |
rs2424715 | 0.90[ASN][1000 genomes] |
rs2424716 | 0.81[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs2482906 | 0.87[AMR][1000 genomes];0.80[EUR][1000 genomes];0.84[ASN][1000 genomes] |
rs2482911 | 0.88[AMR][1000 genomes];0.83[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs2482913 | 0.89[AFR][1000 genomes];0.96[AMR][1000 genomes];0.83[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs2482918 | 0.88[AMR][1000 genomes];0.81[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs2482919 | 0.83[AFR][1000 genomes] |
rs2482923 | 0.80[AFR][1000 genomes] |
rs2482927 | 0.84[AFR][1000 genomes];0.86[AMR][1000 genomes] |
rs2482928 | 0.82[AMR][1000 genomes] |
rs2482930 | 0.82[AMR][1000 genomes] |
rs2482931 | 0.83[AFR][1000 genomes];0.88[AMR][1000 genomes] |
rs2482932 | 0.81[AMR][1000 genomes] |
rs2482937 | 0.85[AMR][1000 genomes] |
rs2482940 | 0.88[AFR][1000 genomes];0.92[AMR][1000 genomes] |
rs2482941 | 0.89[AFR][1000 genomes];0.92[AMR][1000 genomes] |
rs2482943 | 0.91[AFR][1000 genomes];0.94[AMR][1000 genomes];0.84[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs2482948 | 0.83[AFR][1000 genomes] |
rs2500399 | 0.85[AFR][1000 genomes];0.92[AMR][1000 genomes] |
rs2500400 | 0.85[AMR][1000 genomes] |
rs2500401 | 0.86[AMR][1000 genomes] |
rs2500404 | 0.89[AFR][1000 genomes];0.92[AMR][1000 genomes] |
rs2500405 | 0.89[AFR][1000 genomes];0.92[AMR][1000 genomes] |
rs2500406 | 0.93[ASN][1000 genomes] |
rs2500417 | 0.88[AMR][1000 genomes];0.84[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs2500418 | 0.89[AFR][1000 genomes];0.94[AMR][1000 genomes];0.84[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs2500424 | 0.93[AFR][1000 genomes];0.94[AMR][1000 genomes];0.83[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs2500433 | 0.83[AFR][1000 genomes] |
rs2500436 | 0.88[AMR][1000 genomes];0.83[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs2500443 | 0.82[AMR][1000 genomes] |
rs2500446 | 0.85[AMR][1000 genomes] |
rs2500448 | 0.87[AFR][1000 genomes];0.94[AMR][1000 genomes];0.83[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs2856 | 0.85[ASN][1000 genomes] |
rs34645895 | 0.82[ASN][1000 genomes] |
rs3761117 | 0.81[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs397119 | 0.81[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs398036 | 0.81[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs401166 | 0.81[EUR][1000 genomes] |
rs404394 | 0.81[EUR][1000 genomes] |
rs408853 | 0.80[EUR][1000 genomes] |
rs416745 | 0.81[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs422424 | 0.81[EUR][1000 genomes] |
rs422844 | 0.81[EUR][1000 genomes] |
rs447722 | 0.81[EUR][1000 genomes] |
rs448396 | 0.81[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs453329 | 0.81[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs454723 | 0.81[EUR][1000 genomes];0.80[ASN][1000 genomes] |
rs4813561 | 0.81[AMR][1000 genomes] |
rs4813563 | 0.81[AMR][1000 genomes] |
rs4813566 | 0.84[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs4815407 | 0.81[AMR][1000 genomes] |
rs4815408 | 0.80[AMR][1000 genomes] |
rs4815417 | 0.81[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs4815418 | 0.81[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs4815420 | 0.81[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs4815421 | 0.81[AMR][1000 genomes];0.81[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs4815423 | 0.82[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs4815424 | 0.84[AMR][1000 genomes];0.83[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs4815425 | 0.87[ASN][1000 genomes] |
rs4815426 | 0.81[AMR][1000 genomes];0.81[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs6037086 | 0.84[AFR][1000 genomes] |
rs6037095 | 0.80[AMR][1000 genomes] |
rs6037103 | 0.84[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs6037105 | 0.81[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs6037120 | 0.81[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs6037121 | 0.85[ASN][1000 genomes] |
rs6050559 | 0.80[AMR][1000 genomes] |
rs6050562 | 0.80[AMR][1000 genomes] |
rs6050566 | 0.81[AMR][1000 genomes] |
rs6050583 | 0.81[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs6050590 | 0.81[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs6050595 | 0.81[AMR][1000 genomes];0.90[ASN][1000 genomes] |
rs6050598 | 0.81[AMR][1000 genomes];0.81[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs6050599 | 0.81[AMR][1000 genomes];0.81[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs6050600 | 0.90[ASN][1000 genomes] |
rs6050601 | 0.93[ASN][1000 genomes] |
rs6050602 | 0.81[AMR][1000 genomes];0.81[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs6050609 | 0.81[AMR][1000 genomes];0.90[ASN][1000 genomes] |
rs6050611 | 0.86[AMR][1000 genomes];0.81[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs6050617 | 0.90[ASN][1000 genomes] |
rs6050626 | 0.85[ASN][1000 genomes] |
rs6050629 | 0.85[ASN][1000 genomes] |
rs6050630 | 0.85[ASN][1000 genomes] |
rs6050631 | 0.81[EUR][1000 genomes] |
rs6050632 | 0.85[ASN][1000 genomes] |
rs6076339 | 0.85[AMR][1000 genomes] |
rs6076345 | 0.81[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs6076346 | 0.80[AMR][1000 genomes];0.80[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs6083828 | 0.82[AMR][1000 genomes];0.90[ASN][1000 genomes] |
rs6083838 | 0.81[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs6083844 | 0.81[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs6083847 | 0.81[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs6083853 | 0.87[AFR][1000 genomes];0.90[AMR][1000 genomes];0.82[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs6083855 | 0.81[AMR][1000 genomes];0.81[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs6083856 | 0.88[AMR][1000 genomes];0.83[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs6083862 | 0.81[AMR][1000 genomes];0.90[ASN][1000 genomes] |
rs6107033 | 0.85[AMR][1000 genomes] |
rs6107044 | 0.87[AFR][1000 genomes];0.83[AMR][1000 genomes];0.83[ASN][1000 genomes] |
rs6107045 | 0.81[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs6107046 | 0.81[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs6107047 | 0.81[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs6115182 | 0.81[AMR][1000 genomes];0.90[ASN][1000 genomes] |
rs6115185 | 0.85[ASN][1000 genomes] |
rs6115191 | 0.81[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs6132833 | 0.87[AFR][1000 genomes];0.89[AMR][1000 genomes];0.81[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs6132835 | 0.85[ASN][1000 genomes] |
rs6138571 | 0.81[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs6138572 | 0.84[AFR][1000 genomes];0.86[AMR][1000 genomes];0.81[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs6138575 | 0.84[AFR][1000 genomes];0.83[AMR][1000 genomes];0.81[EUR][1000 genomes];0.83[ASN][1000 genomes] |
rs6515651 | 0.81[AMR][1000 genomes];0.81[EUR][1000 genomes];0.90[ASN][1000 genomes] |
rs7270835 | 0.80[AMR][1000 genomes];0.81[EUR][1000 genomes];0.88[ASN][1000 genomes] |
rs761025 | 0.81[EUR][1000 genomes];0.85[ASN][1000 genomes] |
rs8113919 | 0.92[AFR][1000 genomes];0.94[AMR][1000 genomes];0.83[EUR][1000 genomes];0.93[ASN][1000 genomes] |
rs8123949 | 0.81[AMR][1000 genomes];0.82[EUR][1000 genomes];0.90[ASN][1000 genomes] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv1063494 | chr20:25067286-25468557 | Enhancers Active TSS Weak transcription Transcr. at gene 5' and 3' Strong transcription Flanking Active TSS Bivalent Enhancer Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 53 gene(s) | inside rSNPs | diseases |
2 | nsv1063016 | chr20:25067286-25475629 | Enhancers Weak transcription Strong transcription Genic enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 53 gene(s) | inside rSNPs | diseases |
3 | nsv1065101 | chr20:25068046-25466542 | Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 53 gene(s) | inside rSNPs | diseases |
4 | nsv544220 | chr20:25068046-25466542 | Flanking Active TSS Weak transcription Strong transcription Enhancers Genic enhancers Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 53 gene(s) | inside rSNPs | diseases |
5 | nsv531480 | chr20:25070067-25472684 | Enhancers Flanking Active TSS Strong transcription Weak transcription Genic enhancers Active TSS Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 53 gene(s) | inside rSNPs | diseases |
6 | nsv585746 | chr20:25071454-25470056 | Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent/Poised TSS Strong transcription Genic enhancers ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 53 gene(s) | inside rSNPs | diseases |
7 | nsv1062742 | chr20:25071454-25475629 | Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Strong transcription Bivalent/Poised TSS ZNF genes & repeats Active TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 53 gene(s) | inside rSNPs | diseases |
8 | nsv949389 | chr20:25071454-25506582 | Strong transcription Genic enhancers Flanking Active TSS ZNF genes & repeats Weak transcription Enhancers Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 54 gene(s) | inside rSNPs | diseases |
9 | nsv531481 | chr20:25080583-25448944 | Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers ZNF genes & repeats Strong transcription Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 52 gene(s) | inside rSNPs | diseases |
10 | nsv949479 | chr20:25096494-25467359 | Weak transcription Enhancers Bivalent Enhancer Strong transcription Active TSS Bivalent/Poised TSS Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 52 gene(s) | inside rSNPs | diseases |
11 | nsv1061109 | chr20:25101715-25472685 | Enhancers Weak transcription Genic enhancers Strong transcription Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 52 gene(s) | inside rSNPs | diseases |
12 | nsv544221 | chr20:25101715-25472685 | Enhancers Weak transcription Active TSS Strong transcription ZNF genes & repeats Genic enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 52 gene(s) | inside rSNPs | diseases |
13 | nsv833948 | chr20:25231726-25410540 | Strong transcription Enhancers Weak transcription Flanking Active TSS ZNF genes & repeats Genic enhancers Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 20 gene(s) | inside rSNPs | diseases |
14 | nsv482647 | chr20:25308912-25481982 | Enhancers Flanking Active TSS Weak transcription Genic enhancers Active TSS ZNF genes & repeats Strong transcription Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 21 gene(s) | inside rSNPs | diseases |
15 | nsv1056997 | chr20:25316663-25492339 | Strong transcription Weak transcription Genic enhancers Active TSS Enhancers Flanking Active TSS ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 20 gene(s) | inside rSNPs | diseases |
16 | nsv1061058 | chr20:25327960-25388841 | Flanking Active TSS Enhancers Strong transcription Active TSS Weak transcription ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 16 gene(s) | inside rSNPs | diseases |
17 | nsv964440 | chr20:25351740-25387631 | Enhancers Weak transcription Flanking Active TSS Active TSS ZNF genes & repeats Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive region | 13 gene(s) | inside rSNPs | diseases |
18 | nsv1067379 | chr20:25355484-25593240 | Enhancers Weak transcription Flanking Active TSS Strong transcription Genic enhancers Active TSS ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 24 gene(s) | inside rSNPs | diseases |
19 | nsv1061398 | chr20:25370106-25444076 | Enhancers Flanking Active TSS Active TSS Weak transcription Genic enhancers Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionmiRNA target site | 19 gene(s) | inside rSNPs | diseases |
SNP | Gene | Cis/trans | Tissue | Source |
---|---|---|---|---|
rs2500423 | GINS1 | Cis_1M | lymphoblastoid | RTeQTL |
rs2500423 | PYGB | cis | multi-tissue | Pritchard |
rs2500423 | PYGB | cis | Whole Blood | GTEx |
rs2500423 | PYGB | cis | Skin Sun Exposed Lower leg | GTEx |
rs2500423 | ABHD12 | Cis_1M | lymphoblastoid | RTeQTL |
rs2500423 | ABHD12 | cis | Nerve Tibial | GTEx |
rs2500423 | ABHD12 | cis | multi-tissue | Pritchard |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:25372000-25378000 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |
2 | chr20:25372000-25379000 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr20:25372200-25377600 | Weak transcription | Duodenum Mucosa | Duodenum |
4 | chr20:25372200-25377600 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
5 | chr20:25372200-25379000 | Weak transcription | Brain Angular Gyrus | brain |
6 | chr20:25372200-25379000 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |
7 | chr20:25372200-25380800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr20:25372400-25375000 | Weak transcription | GM12878-XiMat | blood |
9 | chr20:25372400-25377800 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
10 | chr20:25372400-25379000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
11 | chr20:25372400-25379200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr20:25374000-25376000 | Enhancers | Fetal Thymus | thymus |
13 | chr20:25374200-25375400 | Enhancers | Brain Anterior Caudate | brain |
14 | chr20:25374200-25375800 | Bivalent Enhancer | HepG2 | liver |
15 | chr20:25374200-25376000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
16 | chr20:25374400-25375000 | Enhancers | Brain Cingulate Gyrus | brain |
17 | chr20:25374400-25375200 | Enhancers | Brain Hippocampus Middle | brain |
18 | chr20:25374400-25375400 | Enhancers | Thymus | Thymus |
19 | chr20:25374400-25375800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
20 | chr20:25374600-25375000 | Enhancers | Brain Inferior Temporal Lobe | brain |
21 | chr20:25374600-25375200 | Enhancers | Brain Substantia Nigra | brain |
22 | chr20:25374600-25375400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
23 | chr20:25374800-25375200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
24 | chr20:25374800-25379400 | Weak transcription | Hela-S3 | cervix |